New study aims to reduce side effects of prostate cancer treatment
NCT ID NCT05526248
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 30 times
Summary
This study looked at two drugs, darolutamide and enzalutamide, in men with prostate cancer that had returned after initial treatment but had not yet spread. The goal was to see how each drug affects testosterone levels and related side effects like breast tenderness. 28 men participated, taking one of the two drugs for up to a year, with regular blood tests and scans to monitor their cancer and overall health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOCHEMICALLY RECURRENT PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beth Israel Deaconess Medical Center - Oncology
Boston, Massachusetts, 02215, United States
-
Central Ohio Urology Group - Gahanna
Gahanna, Ohio, 43230, United States
-
Mass General Cancer Center
Boston, Massachusetts, 02114-2696, United States
-
Memorial Sloan Kettering Cancer Center New York - Main Campus
New York, New York, 10065, United States
-
Unio Specialty Care - Urology - Sherman Oaks
Sherman Oaks, California, 91411, United States
Conditions
Explore the condition pages connected to this study.